Conopio, Joshua D.

HRN: 23-20-01  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/12/2023
CEFTRIAXONE 1G (VIAL)
06/12/2023
06/18/2023
IV
2gm
Q24
Uti
Waiting Final Action 
06/13/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/13/2023
06/19/2023
IV DRIP
500 Mg
Q8
TC Typhoid Ilietis
Waiting Final Action 
06/15/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
06/15/2023
06/22/2023
IV
4.2g
Q6h
Ruptured Appendicitis
Waiting Final Action 
06/17/2023
GENTAMICIN 40MG/ML, 2ML (AMP)
06/17/2023
06/23/2023
IVT
200mg
Q24h
Ruptured Acute AP With Generalized Peritonitis
Waiting Final Action 
06/21/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/21/2023
06/28/2023
IV
500 Mg
Q8h
Acute Ruptured Appendicitis
Waiting Final Action 
06/22/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
06/22/2023
06/29/2023
IV
300mg
Q6H
Ruptured Appendicitis
Waiting Final Action 
06/24/2023
MUPIROCIN 2%, 15G (TUBE)
06/24/2023
07/01/2023
TOPICAL
Apply To Affected Area
Twice Daily
Empiric
Waiting Final Action 
06/25/2023
AZITHROMYCIN 500MG TABLET (TAB)
06/25/2023
06/30/2023
PO
500mg
OD
Pneumonia
Waiting Final Action 
06/25/2023
CIPROFLOXACIN 500MG (TAB)
06/25/2023
07/01/2023
PO
500mgtab
BID
Sepsis
Waiting Final Action 
06/27/2023
MUPIROCIN 2%, 15G (TUBE)
06/27/2023
07/04/2023
TOPICAL
Apply To Affected Area
Twice A Day
Empiric
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: